These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 6368735)

  • 1. Natural resistance of lethally irradiated F1 hybrid mice to parental marrow grafts is a function of H-2/Hh-restricted effectors.
    Daley JP; Nakamura I
    J Exp Med; 1984 Apr; 159(4):1132-48. PubMed ID: 6368735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ability of H-2Dd molecule to affect natural resistance to hemopoietic allografts is an intrinsic property shared by Ddm1 but not Ld.
    Milisauskas VK; Nakamura I
    Eur J Immunol; 1994 Feb; 24(2):336-42. PubMed ID: 8299682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ly-49 G2+ NK cells are responsible for mediating the rejection of H-2b bone marrow allografts in mice.
    Raziuddin A; Longo DL; Mason L; Ortaldo JR; Murphy WJ
    Int Immunol; 1996 Dec; 8(12):1833-9. PubMed ID: 8982767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific inhibition of hybrid resistance in F1 hybrid mice pretreated with parent-strain spleen cells. II. Evidence for an Hh-1 antigen-specific tolerization.
    Kosmatopoulos K; Scott-Algara D; Halle-Pannenko O
    J Immunol; 1988 Nov; 141(10):3285-92. PubMed ID: 2460528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of the K and I regions of the H-2 complex in resistance to hemopoietic allografts.
    Drizlikh G; Schmidt-Sole J; Yankelevich B
    J Exp Med; 1984 Apr; 159(4):1070-82. PubMed ID: 6142918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Class I H-2Db determinants are not involved in hybrid resistance to parental H-2b/Hh-1b bone marrow allograft.
    Milisauskas VK; Kaminsky SG; Nakamura I
    Eur J Immunol; 1987 Jul; 17(7):1043-9. PubMed ID: 2440692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nature of hemopoietic histocompatibility determinants. Differential sensitivity of Hh-1b and H-2b determinants to tunicamycin.
    Milisauskas VK; Nakamura I
    J Immunol; 1988 Aug; 141(4):1246-51. PubMed ID: 2456347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of hemopoietic histocompatibility antigens on H-2-loss variants of F1 hybrid lymphoma cells: evidence consistent with trans gene regulation.
    Rembecki RM; Bennett M; Kumar V; Potter TA
    J Immunol; 1987 Apr; 138(8):2734-8. PubMed ID: 3549904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemopoietic histocompatibility (Hh-1) phenotype and the regulation of its expression.
    Kaminsky SG; Yoshida MA; Milisauskas VK; Nakamura I
    Immunogenetics; 1992; 35(2):117-25. PubMed ID: 1735558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effector cell expression of NK1.1, a murine natural killer cell-specific molecule, and ability of mice to reject bone marrow allografts.
    Sentman CL; Kumar V; Koo G; Bennett M
    J Immunol; 1989 Mar; 142(6):1847-53. PubMed ID: 2646375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized.
    Murphy WJ; Kumar V; Bennett M
    J Exp Med; 1987 Nov; 166(5):1499-509. PubMed ID: 3316472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine cytomegalovirus infection can enhance hybrid resistance through modulation of host natural killer activity.
    Muluk SC; Hakim FT; Shearer GM
    J Immunol; 1990 Aug; 145(4):1113-9. PubMed ID: 2166108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abrogation of hybrid resistance to bone marrow engraftment by graft-vs-host-induced immune deficiency.
    Hakim FT; Shearer GM
    J Immunol; 1986 Nov; 137(10):3109-16. PubMed ID: 3095424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of bone marrow allograft rejection and hybrid resistance in nonresponder recipients by antibody: is there evidence for a dual receptor interaction in acute marrow graft rejection?
    Dennert G; Anderson CG; Warner J
    J Immunol; 1986 Jun; 136(11):3981-6. PubMed ID: 3517162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid rejection of H2k and H2k/b bone marrow cell grafts by CD8+ T cells and NK cells in irradiated mice.
    Davenport C; Kumar V; Bennett M
    J Immunol; 1995 Oct; 155(8):3742-9. PubMed ID: 7561078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of genetic resistance to marrow grafts in mice by interferon-alpha/beta.
    Afifi MS; Kumar V; Bennett M
    J Immunol; 1985 Jun; 134(6):3739-45. PubMed ID: 2985694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rejection of bone marrow cell allografts by natural killer cell subsets: 5E6+ cell specificity for Hh-1 determinant 2 shared by H-2d and H-2f.
    Sentman CL; Kumar V; Bennett M
    Eur J Immunol; 1991 Nov; 21(11):2821-8. PubMed ID: 1718761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybrid resistance to EL-4 lymphoma cells. I. Characterization of natural killer cells that lyse EL-4 cells and their distinction from marrow-dependent natural killer cells.
    Kumar V; Luevano E; Bennett M
    J Exp Med; 1979 Sep; 150(3):531-47. PubMed ID: 383877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NK-mediated elimination of mutant lymphocytes that have lost expression of MHC class I molecules.
    Kusunoki Y; Kyoizumi S; Honma M; Kubo Y; Ohnishi H; Hayashi T; Seyama T
    J Immunol; 2000 Oct; 165(7):3555-63. PubMed ID: 11034355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic control of the target structures recognized in hybrid resistance.
    Daley JP; Wroblewski JM; Kaminsky SG; Nakamura I
    Immunogenetics; 1987; 26(1-2):21-30. PubMed ID: 3301648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.